Exploring Machine Learning for Rare Diseases: A Study Using Nature Methods

Date:

Recent advancements in high-throughput profiling methods, such as genomics and imaging, have revolutionized medical research and enabled an elaborate understanding of the molecular mechanisms and pathways underlying several diseases. Machine learning (ML) is a powerful tool to extract significant patterns from these high dimensional datasets. But due to its complexity, it usually requires a large sample size to identify essential patterns. However, when dealing with rare diseases, the clinical cases tend to be quite limited, making it a difficult task to perform ML on these samples. In this Perspective, we focus on addressing the specific challenges related to employing ML for rare disease research, considering the limited samples. We also emphasize potential solutions to the problem and suggest that ML techniques with limited samples should be given preference and be developed further. With the goal of further advancing rare diseases, this could also potentially broaden ML applications to cases which have few samples with high-dimensional data.

See also  Jamia Milia Islamia to Organize Three-Week Training Program on AI and Machine Learning Next Month

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.